Historical salary details - Dr. Laura Sepp-Lorenzino, PhD, Executive Vice President and Chief Scientific Officer, Intellia Therapeutics Inc
Dr. Laura Sepp-Lorenzino, PhD has been the Executive Vice President and Chief Scientific Officer of Intellia Therapeutics Inc since 14 Jan 2019. View his historical salary.
Dr. Laura Sepp-Lorenzino, Phd
Executive Vice President and Chief Scientific Officer
-
Gross Remuneration
-
Current Company
Intellia Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Intellia Therapeutics Inc | Executive Vice President and Chief Scientific Officer | - | - |
| 2023 | Intellia Therapeutics Inc | Executive Vice President and Chief Scientific Officer | 4.2 M | 12.6 % |
| 2022 | Intellia Therapeutics Inc | Executive Vice President and Chief Scientific Officer | 3.7 M | -18.9 % |
| 2021 | Intellia Therapeutics Inc | - | 4.6 M | 170.9 % |
| 2021 | Intellia Therapeutics Inc | Executive Vice President and Chief Scientific Officer | 4.6 M | 170.9 % |
| 2020 | Intellia Therapeutics Inc | - | 1.7 M | -4.1 % |
| 2020 | Intellia Therapeutics Inc | - | 1.7 M | -4.1 % |
| 2020 | Intellia Therapeutics Inc | Executive Vice President and Chief Scientific Officer | 1.7 M | -4.1 % |
| 2019 | Intellia Therapeutics Inc | - | 1.8 M | - |
| 2019 | Intellia Therapeutics Inc | - | 1.8 M | - |
| 2019 | Intellia Therapeutics Inc | Executive Vice President and Chief Scientific Officer | 1.8 M | - |